InvestorQ : What is the latest on the COVID vaccine testing by Sanofi and Glaxo?
sara Kunju made post

What is the latest on the COVID vaccine testing by Sanofi and Glaxo?

Answer
user profile image
Mary Joseph answered.
3 weeks ago


You may recollect that Sanofi and Glaxo had jointly developed the adjuvanted COVID vaccine. Both the pharma majors are all set to start phase 1 and 2 of human clinical trials from late this week or early next week. This is the first step in human trials.

The two pharma companies will enrol around 440 healthy adults in this phased of the trials across 11 sites in the US. The first clear results are expected to be available around the first week of December. Post that only Phase 3 of the trial will commence.

At this point, there are nearly 30 COVID-19 vaccine candidates that are currently undergoing human trials at different stages. The joint product of Sanofi and Glaxo is slightly late with specific players like Astra Zeneca and Oxford Research Centre already on the job.

Both Sanofi and Glaxo Pharma confirmed that the pre-clinical data had shown an acceptable reactogenicity profile and two injections of the vaccine led to high levels of neutralising antibodies. The findings of the data are expected to be announced late this year.